Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Morningstar

What to Do When Your ETF Closes

Not all ETFs succeed. Here's what to look out for and what to do if a fund you own closes.

PepsiCo Hiked Its Dividend 5% and its Yield is over 3.93% - A Buy Now for Value Investors?

PepsiCo Hiked Its Dividend 5% and its Yield is over 3.93% - A Buy Now for Value Investors?

PepsiCo announced a 5% dividend hike starting in June. Based on this, PEP stock has a dividend yield of over 3.93%, 42% higher than its average yield over the last five years. This makes it attractive to value investors.

Kroger hires PepsiCo exec for CFO role as grocery battles heat up

Kroger hires PepsiCo exec for CFO role as grocery battles heat up

Traditional supermarkets like Kroger must compete with mass merchandise and warehouse club channels, says a Morningstar analyst.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Investors Bullish on NextEra Energy - Huge Unusual Call Options Activity - Dividend Hikes Likely

Today a large, unusual amount of long-dated call options were traded in NextEra Energy - a bullish outlook on NEE stock. Management said it will hike the dividend by 10% annually for the next 2 years.

4 financial tasks you shouldn’t put off

You’ve probably got one or two financial jobs on your to-do list that you were too busy to get to or perceived as boring administrative work

The Independent UK

3 steps to uncovering your true financial goals

If your financial goals are hard to pin down, or seem to drift, you’re not alone

The Independent UK

Meme coins: Fun hobby or wild gamble?

The digital tokens started as internet memes, but investors are increasingly in on the joke

inkl

Read news from The Economist, FT, and more,
with one subscription

Verona Pharma Keeps Hitting New Highs

Verona Pharma Keeps Hitting New Highs

Summary Verona Pharma (VRNA) shows strong technical indicators with a 54.89% gain since 11/19, driven by Barchart's Trend Seeker buy signal. The company focuses on developing ensifentrine for respiratory diseases, currently in Phase 3 trials, with multiple inhaler formulations. Barchart's technical indicators highlight 100% buy signals, a 222.12% gain in...

Chevron's Dividend Hike Shows CVX Stock is Too Cheap

Chevron's Dividend Hike Shows CVX Stock is Too Cheap

Chevron Corp hiked its annual dividend by 5%, as its free cash flow was strong and positive, although lower than last year. Nevertheless, CVX is undervalued as its 4.55% yield is well over the 4.23% historical average.

Franklin Resources Stock Looks Like a Bargain With Its 6.38% Yield

Franklin Resources Stock Looks Like a Bargain With Its 6.38% Yield

Franklin Resources has a 6.38% annual dividend yield and looks like a bargain. Moreover, its average yield over the last 5 years is much lower at 4.40%. That implies BEN stock could be worth much more.

Ease the Tax Bite When You Tap Retirement Accounts

Ease the Tax Bite When You Tap Retirement Accounts

Savvy retirees tap retirement accounts with a tax plan. Each type of account may have different tax rules and rates, so know before withdrawing funds.

How AI Will Impact Our Lives in 2025 and Beyond

How AI Will Impact Our Lives in 2025 and Beyond

Now that breakthrough artificial intelligence is here, the next decade of computing will be dominated by AI.

Delcath Systems - Super Growth Projections

Delcath Systems - Super Growth Projections

Summary Delcath Systems (DCTH) shows strong technical buy signals, with a 53.41% gain since 1/25 and a 271.33% gain in the last year. The company focuses on liver cancer treatments, with its leading product HEPZATO KIT and ongoing FOCUS clinical trial for metastatic uveal melanoma. Barchart indicators highlight 100% technical...

Xiaomi - Outselling Tesla in China

Xiaomi - Outselling Tesla in China

Summary Xiaomi Corporation's stock (XIACY) has shown strong technical buy signals and significant price appreciation, gaining 19.25% since the Trend Seeker buy signal on 12/2. The company operates in multiple segments, including smartphones, IoT products, internet services, and smart electric vehicles, with a market cap of $110 billion. Barchart's technical...

Get all your
news in one place.

100's of premium titles.
One news app.

What Were the 3 Best-Performing Dividend Stocks in 2024?

Morningstar research shows that these high-yielding dividend stocks were winners last year. Can they keep up the outperformance in 2025?

The Independent UK

What to do with your 401(k) when you retire

For many employees, what to do with a 401(k) plan at retirement has been a foregone conclusion: Roll it over

Apple's new chief financial officer will use the same 'CFO playbook' say top analysts—and that's good news for investors

Kevan Parekh, who first joined the company in 2013, begins his tenure as finance chief.

Tencent loses billions in market value after the U.S. alleges the video game giant has links to China’s military

The Department of Defense accused Tencent and EV battery giant CATL of having ties to China’s military. Tencent calls the decision “clearly a mistake.”

Get all your
news in one place.

100's of premium titles.
One news app.

The Pros and Cons of Investing in Private Debt

What to know about investing in private debt, including how it works and where to invest.

Tarsus Pharmaceutical - Eye Care Therapeutics

Summary Tarsus Pharmaceuticals (TARS) has shown strong technical indicators, including a 48.35% gain since the Trend Seeker buy signal on 9/4 and 173.43% gain in the last year. The company focuses on novel eye care therapeutics, with its lead product XDEMVY targeting blepharitis caused by Demodex mites and other promising...

The Independent UK

3 must-knows about employee stock options

If stock options are part of your compensation package, it’s worth your while to get familiar with how they work generally, as well as how your company handles stock options specifically

Chevron Stock Looks Cheap, Especially if it Hikes the Dividend

Chevron may raise its dividend based on its strong free cash flow. CVX looks undervalued now, trading at lows. If Chevron raises the dividend by 6.75%, the forward yield is now very high at 4.85%.

The Independent UK

Should you worry about overfunding your 529 plan?

529 college savings plans are powerful tools to help pay for the mounting costs of an education

Four Lessons for a Happy, Successful and Wealthy Retirement

Christine Benz, Morningstar director of personal finance and retirement planning, explains the key lessons from her book on retiring successfully.

Maximize Tax Savings With Strategic Tax-Loss Selling

Learn how tax-loss selling can optimize your portfolio for growth and tax efficiency. Explore Morningstar's personal finance section for more insights.

1 … 9 10 11 12

People

193,965 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

The Associated Press

Intel Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

electric vehicle

Financial Goals

Places

381,941 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play